• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AOMORI OLYMPUS CO., LTD. DISPOSABLE DISTAL ATTACHMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AOMORI OLYMPUS CO., LTD. DISPOSABLE DISTAL ATTACHMENT Back to Search Results
Model Number D-201-11804
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hemorrhage/Bleeding (1888); Perforation (2001)
Event Date 07/08/2023
Event Type  Injury  
Event Description
Olympus medical systems corp.Received a literature titled "predictive factors for the outcome of unsupervised endoscopic submucosal dissection during the initial learning curve with prevalence-based indication".This retrospective study analyzed possible predictors for effectiveness and safety outcome parameters during the initial learning curve.A total of 480 esds were enrolled.Ebr was achieved in 84.5% (394/466) of technically successful resections.Multivariable logistic regression analysis revealed pl as negative independent predictor (or 0.27 [0.13¿0.57], p<0.001) and interventions in the esophagus (or 7.80, p<0.001), stomach (or 5.72 [2.36¿13.89], p<0.001), and rectum (or 2.29, p=0.007) as positive independent predictors for ebr.Complications occurred in 9.5% (8/84) of esophageal, 13.3% (15/113) of gastric, 16.0% (29/181) of rectal, and 15.8% (16/101) of colonic esds.There were 14/480 (2.9%) resections that were technically unsuccessful.Complications and fibrosis/pretreatment mainly caused technical failure.In conclusion, during the initial learning curve of an unsupervised esd program with prevalence-based indication, pretreated lesions and colonic esds should be avoided.In contrast, lesion size and organ-based localizations have less predictive value for the outcome.Type of adverse events/number of patients.Event 1:bleeding (27) including patient#2,4,13 in table 4.Event 2:perforation (41) including patient #3,6,7,11,12,14 in table 4.Complications occurred in 14.2% (68/480) of the cases with 27 (5.6%) bleedings and 41 (8.5%) perforations (table 2).Therapy of bleeding was conservative in 14.8% (4/27) and endoscopic in 85.2% (23/27) per patient.Therapy of perforation was conservative in 9.8% (4/41), endoscopic in 75.6% (31/41), and surgical in 14.6% (6/41) of the cases this event requires thirty (30) reports.The patient identifiers are as follows: 1.(b)(6): kd-650q, for non-identified patients.2.(b)(6): kd-620qr, for non-identified patients.3.(b)(6): d-201-11804, for non-identified patients.4.(b)(6): kd-650q, for patient#2 (age 78/sex m) in table4.5.(b)(6): kd-620qr, for patient#2 (age 78/sex m) in table4.6.(b)(6): d-201-11804, for patient#2 (age 78/sex m) in table4.7.(b)(6): kd-650q, for patient#3 (age 68/sex f) in table4.8.(b)(6): kd-620qr, for patient#3 (age 68/sex f) in table4.9.(b)(6): d-201-11804, for patient#3 (age 68/sex f) in table4.10.(b)(6): kd-650q, for patient#4 (age 49/sex m) in table4.11.(b)(6): kd-620qr, for patient#4 (age 49/sex m) in table4.12.(b)(6): d-201-11804, for patient#4 (age 49/sex m) in table4.13.(b)(6): kd-650q, for patient#6 (age 51/sex f) in table4.14.(b)(6): kd-620qr, for patient#6 (age 51/sex f) in table4.15.(b)(6): d-201-11804, for patient#6 (age 51/sex f) in table4.16.(b)(6): kd-650q, for patient#7 (age 66/sex f) in table4.17.(b)(6): kd-620qr, for patient#7 (age 66/sex f) in table4.18.(b)(6): d-201-11804, for patient#7 (age 66/sex f) in table4.19.(b)(6): kd-650q, for patient#11 (age 66/sex m) in table4.20.(b)(6): kd-620qr, for patient#11 (age 66/sex m) in table4.21.(b)(6): d-201-11804, for patient#11 (age 66/sex m) in table4.22.(b)(6): kd-650q, for patient#12 (age 72/sex f) in table4.23.(b)(6): kd-620qr, for patient#12 (age 72/sex f) in table4.24.(b)(6): d-201-11804, for patient#12 (age 72/sex f) in table4.25.(b)(6): kd-650q, for patient#13 (age 92/sex m) in table4.26.(b)(6): kd-620qr, for patient#13 (age 92/sex m) in table4.27.(b)(6): d-201-11804, for patient#13 (age 92/sex m) in table4.28.(b)(6): kd-650q, for patient#14 (age 74/sex m) in table4.29.(b)(6): kd-620qr, for patient#14 (age 74/sex m) in table4.30.(b)(6): d-201-11804, for patient#14 (age 74/sex m) in table4.This report is for (b)(6).There is no report of any olympus device malfunction in any procedure described in this study.
 
Manufacturer Narrative
E1 establishment name: (b)(6).Since the literature described "standard olympus cap" olympus selected "d-201-11804" as representative product.The product was unknown, but a representative product was chosen for processing purposes.The literature article is attached for additional information.The investigation is ongoing.A supplemental report will be submitted upon completion of the investigation or when additional information becomes available.
 
Manufacturer Narrative
This report is being supplemented to provide additional information based on the legal manufacturer's final investigation.The device history record was unable to be reviewed for this device since the serial and/or lot number was not provided.However, olympus only releases products to market that meet all manufacturing specifications and final product release criteria.Based on the results of the investigation, the relationship between the device and the adverse event cannot be confirmed.There was no complaint reported on the subject device and there is no evidence of an olympus device malfunction.Therefore, the root cause cannot be determined.Olympus will continue to monitor field performance for this device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DISPOSABLE DISTAL ATTACHMENT
Type of Device
DISPOSABLE DISTAL ATTACHMENT
Manufacturer (Section D)
AOMORI OLYMPUS CO., LTD.
2-248-1 okkonoki
kuroishi-shi, aomori 036-0 357
JA  036-0357
Manufacturer (Section G)
AOMORI OLYMPUS CO., LTD.
2-248-1 okkonoki
kuroishi-shi, aomori
Manufacturer Contact
todd brill
800 west park drive
westborough, MA 01581
5082077661
MDR Report Key18028769
MDR Text Key326915843
Report Number9614641-2023-01607
Device Sequence Number1
Product Code FDS
UDI-Device Identifier04953170278280
UDI-Public04953170278280
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
K984358
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Study,Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 12/12/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/30/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberD-201-11804
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received12/11/2023
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-